Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above

NCT07285213 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07285213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07285213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Recruiting
Start date
December 10, 2025
Completion date
January 18, 2028
Enrollment
230 (estimated)
Sites
117

Conditions

As the registry lists them; a condition with its own page is linked.

clostridioides difficile infection